U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07025551) titled 'A Clinical Study of MK-8527 in Participants With Mild and Moderate Hepatic Impairment (MK-8527-015)' on June 09.
Brief Summary: The purpose of this study is to learn what happens to MK-8527 in a person's body over time (a pharmacokinetic [PK] study). Researchers will compare what happens to MK-8527 in the body when it is given to healthy participants and participants with mild and moderate hepatic (liver) impairment.
Study Start Date: Aug. 11
Study Type: INTERVENTIONAL
Condition:
Hepatic Impairment
Healthy Participants
Intervention:
DRUG: MK-8527
Oral administration
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Merck Shar...